Programming - Vascular Discovery: from Genes to Medicine Scientific Sessions 2022

Learning Studio: Clinical Insights in CAD and/or PAD: Reducing the Risk of Major Cardiovascular Events

Friday, May 13, 2022
12 p.m. – 12:30 p.m.
Grand Ballroom D
David Dexter, MD

Patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) are at risk for major cardiovascular events, including cardiovascular death, myocardial infarction, stroke, ischemic stroke, acute limb ischemia, and major amputation of a vascular etiology. This lecture will discuss an approach to reducing the risk of these events.

This event supported by Janssen Pharmaceuticals, Inc. Complimentary food & beverage provided by the American Heart Association. No preregistration is required, but seating is limited.

This event is not part of the accredited Vascular Discovery 2022 Scientific Sessions.

Vascular Discovery 2022 Program Committee

Katey Rayner, PhD

Katey Rayner, PhD
Conference Chair
University of Ottawa Heart Institute
Ottawa, Ontario, Canada

Kathleen A Martin, PhD

Kathleen A. Martin, PhD
Conference Vice-Chair
Yale University School of Medicine
New Haven, Connecticut


  • Luke P. Brewster, MD, PhD, RVT, Emory University, Atlanta, Georgia
  • Mete Civelek, PhD, University of Virginia, Charlottesville, Virginia
  • Ebru Erbay, MD, PhD, Cedars Sinai Medical Center, Los Angeles, California
  • Jason Fish, PhD, Toronto General Research Institute, Toronto, Ontario, Canada
  • Naomi M. Hamburg, MD, Boston University School of Medicine, Boston, Massachusetts
  • Peter Henke, MD, University of Michigan, Ann Arbor, Michigan
  • Ngan F. Huang, PhD, Stanford University, Stanford, California
  • Luisa Iruela Arispe, PhD, Northwestern University, Chicago, Illinois
  • Yogendra Kanthi, MD, University of Michigan, Ann Arbor, Michigan
  • Milka Koupenova, PhD, University of Massachusetts Medical School, Worcester, Massachusetts
  • Esther Lutgens, MD, PhD, Amsterdam University Medical Center, Amsterdam, Netherlands
  • Lars Maegdefessel, MD, PhD, Immediate Past Conference Chair, Technical University Munich, Munich, Germany
  • Clint Miller, PhD, University of Virginia, Charlottesville, Virginia
  • Pradeep Natarajan, MD, MSc, Massachusetts General Hospital, Boston, Massachusetts
  • Manuel F. Navedo, PhD, University of California-Davis, Davis, California
  • A. Phillip Owens, PhD, University of Cincinnati, Cincinnati, Ohio
  • Babak Razani, MD, PhD, Washington University School of Medicine, St. Louis, Missouri
  • Alan T. Remaley, MD, PhD, NIH/NHLBI, Bethesda, Maryland
  • Kerry Anne Rye, PhD, FAHA, University of New South Wales, Sydney, NSW, Australia
  • Nalini Santanam, PhD, MPH, Marshall University School of Medicine, Huntington, West Virginia
  • Mary Sorci-Thomas, PhD, FAHA, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Adam Straub, PhD, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Miao Wang, PhD, Chinese Academy of Medical Sciences, Beijing, China
  • Marit Westerterp, PhD, University of Groningen, Groningen, Netherlands
  • Randal J. Westrick, PhD, Oakland University, Rochester, Michigan
  • Dennis Wolf, MD, University Heart Center Freiburg, Freiburg, Germany
  • Jun Yu, MD, FAHA, Temple University, Philadelphia, Pennsylvania


  • Elena Aikawa, MD, PhD, Brigham and Women’s Hospital, Boston, Massachusetts
  • Magdalena Chrzanowska, PhD, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Alan Daugherty, PhD, DSc, FAHA, University of Kentucky, Lexington, Kentucky
  • Katherina A. Gallagher, MD, University of Michigan, Ann Arbor, Michigan
  • Iftikhar Kullo, Mayo Clinic, Rochester, Minnesota
  • Muredach P. Reilly, MBBCH, MSCE, FAHA, Columbia University, New York, New York
  • Daisy Sahoo, PhD, Medical College of Wisconsin, Milwaukee, Wisconsin
  • Cynthia St. Hilaire, PhD, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Timothy Stalker, PhD, University of Pennsylvania, Philadelphia, Pennsylvania
  • Francine Welty, MD, PhD, Harvard Medical School, Brookline, Massachusetts
  • Xiaofeng Yang, MD, PhD, Temple University Katz School of Medicine, Philadelphia, Pennsylvania

About this Meeting

This 2 ½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology, the Peripheral Vascular Disease Council, and the Council on Genomic and Precision Medicine, in cooperation with and the Society for Vascular Surgery's Vascular Research Initiatives Conference.

Vascular Discovery 2022 will provide unique opportunities to meet with colleagues from around the world with wide-ranging research interests and expertise for the timely exchange of information about new and emerging scientific research in the areas of arteriosclerosis, thrombosis and vascular biology, peripheral vascular disease, vascular surgery research, genomics and precision medicine. We expect a broad representation from many disciplines and encourage young scientists to attend.

Watch this space for updates on the program and speakers!

Target Audience

The conference will especially appeal to scientists and clinicians interested in: 

  • Allergy and Immunology
  • Arteriosclerosis
  • Biochemistry
  • Biological Sciences
  • Diabetes and Metabolism
  • Functional Genomics
  • Genetics
  • Hematology
  • Internal Medicine
  • Molecular/Cellular Biology
  • Nutrition
  • Pathology
  • Peripheral Artery Disease
  • Pharmacology
  • Physiology
  • Vascular Surgery
  • Thrombosis
  • Vascular Biology
  • Vascular Medicine